Sellas Life Sciences Group Inc (SLS)
Financing Cash Flow
$38.83M
Quarterly · Period ending: · USD
SLS Financing Cash Flow
Latest reported$38.83Mperiod ending
Latest reported$38.83Mperiod ending
SLS Quarterly Cash from Financing ($286.00K → $38.83M)
Quarterly financing cash flow
High-resolution chart · PNG
SLS financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 38,834,000 | |
| 44,150,000 | |
| 32,394,000 | |
| 26,091,000 | |
| 4,230,000 | |
| 23,581,000 | |
| 8,000 | |
| 19,690,000 | |
| 414,000 | |
| 26,646,000 | |
| 3,386,000 | |
| 54,000 | |
| -29,000 | |
| 18,904,000 | |
| 929,000 | |
| 107,000 | |
| 22,996,000 | |
| 47,000 | |
| 50,000 | |
| 2,242,000 | |
| 6,782,000 | |
| 3,000,000 | |
| 23,675,000 | |
| 8,492,000 | |
| -25,000 | |
| 6,300,000 | |
| 2,319,000 | |
| 189,000 | |
| 14,831,000 | |
| 2,230,000 | |
| -76,000 | |
| 14,252,000 | |
| 4,208,000 | |
| 4,739,000 | |
| -15,535,000 | |
| 1,090,000 | |
| 5,655,000 | |
| 19,979,000 | |
| 1,569,000 | |
| 17,132,000 | |
| -3,628,000 | |
| 19,251,000 | |
| -1,009,000 | |
| -759,000 | |
| 4,329,000 | |
| 41,284,000 | |
| 9,855,000 | |
| -334,000 | |
| 19,000 | |
| 14,720,000 | |
| 7,662,000 | |
| 37,740,000 | |
| 10,430,000 | |
| 92,000 | |
| 22,552,000 | |
| 360,000 | |
| 17,359,000 | |
| 2,153,000 | |
| 10,000 | |
| 1,173,000 | |
| 10,722,000 | |
| 7,291,000 | |
| -25,000 | |
| -15,000 | |
| -18,000 | |
| 11,628,000 | |
| -16,000 | |
| 7,706,000 | |
| -6,000 | |
| -4,000 | |
| 21,000 | |
| -20,000 | |
| 7,921,000 | |
| 0 | |
| -204,000 | |
| 1,342,000 | |
| 15,630,000 | |
| 1,065,000 | |
| 286,000 |